Omalizumab Responders Analysis in Nasal Polyposis: A Supplementary Analysis of the Co-Primary Endpoints of POLYP 1 and POLYP 2 TrialsJ. Corren, P. H. Wellings,P. Gevaert,C. Bachert,J. Mullol,X. Jaumont, R. Zhao,R. Saenz,L. Islam,T. OmachiAllergy(2020)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要